SCHEMBL9005586

SCHEMBL9005586

CC(C)C(Oc1cccc(C(=O)O)c1)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.58
KMT2A Q03164 2/20 0.54
RXRA P19793 1/20 0.51
RXRB P28702 1/20 0.51
NR4A2 P43354 2/20 0.50
FOLH1 Q04609 1/20 0.50
KMO O15229 1/20 0.49
NR1H4 Q96RI1 2/20 0.48
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
NR4A1 P22736 1/20 0.46
NR4A3 Q92570 1/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
CYP2C9 P11712 1/20 0.46
RAB9A P51151 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA6 P23280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184304 0.85 RXRA (0.68) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL2878702 0.85 AKR1C3 (0.61) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL592781 0.85 RXRA (0.68) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL27608138 0.84 PARP1 (0.64) KMT2ACES2CES1POLB
SCHEMBL8517905 0.84 AKR1C3 (0.59) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL28317301 0.82 AKR1C3 (0.58) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL2931454 0.81 AKR1C3 (0.56) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL27935297 0.79 AKR1C3 (0.63) AKR1C3KMT2ANR4A2FOLH1KMO
SCHEMBL6623075 0.79 AKR1C3 (0.54) AKR1C3KMT2ARXRARXRBNR4A2
SCHEMBL11040664 0.79 KMT2A (0.61) AKR1C3KMT2ARXRARXRBNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0579223-B1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity MITSUBISHI CHEM CORP (JP) 1996-10-09 EP disclosed
US-5385917-A Treating androgen dependent diseases MITSUBISHI KASEI CORPORATION (JP) 1995-01-31 US disclosed
EP-0579223-A1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity Mitsubishi Chemical Corporation (JP) 1994-01-19 EP disclosed